IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 304 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $252 | +8.6% | 5,550 | -1.8% | 0.25% | +23.8% |
Q2 2023 | $232 | +14.9% | 5,650 | 0.0% | 0.20% | +6.3% |
Q1 2023 | $202 | -16.5% | 5,650 | -11.7% | 0.19% | -25.5% |
Q4 2022 | $242 | -99.9% | 6,400 | 0.0% | 0.26% | -19.6% |
Q3 2022 | $283,000 | +1.1% | 6,400 | +85.5% | 0.32% | +72.3% |
Q1 2019 | $280,000 | +34.6% | 3,450 | -10.4% | 0.18% | +14.3% |
Q4 2018 | $208,000 | -12.6% | 3,850 | -28.7% | 0.16% | -24.8% |
Q1 2018 | $238,000 | -30.4% | 5,400 | -20.6% | 0.21% | -35.0% |
Q4 2017 | $342,000 | -18.2% | 6,800 | -17.6% | 0.33% | -24.9% |
Q3 2017 | $418,000 | +3.5% | 8,250 | +3.8% | 0.44% | -2.2% |
Q2 2017 | $404,000 | +16.1% | 7,950 | -8.1% | 0.45% | +24.8% |
Q1 2017 | $348,000 | -16.9% | 8,650 | -1.1% | 0.36% | -21.8% |
Q4 2016 | $419,000 | -15.0% | 8,750 | -34.9% | 0.46% | -6.9% |
Q3 2016 | $493,000 | +39.7% | 13,450 | -11.2% | 0.49% | +21.7% |
Q2 2016 | $353,000 | -43.2% | 15,150 | -1.3% | 0.40% | -48.0% |
Q1 2016 | $622,000 | -49.5% | 15,350 | -22.9% | 0.78% | -41.1% |
Q4 2015 | $1,232,000 | – | 19,900 | – | 1.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |